John Freeman is a UK-based pharmaceutical executive with over 25 years of experience in oncology drug development. They currently serve as a Senior Director and Development Team Leader at Johnson & Johnson, focusing on innovative therapies for lung cancer. Previously, Freeman held key roles at AstraZeneca, leading the clinical development of TAGRISSO, and at IQVIA, where they oversaw significant portfolio expansions in oncology. With deep expertise across various solid tumors, Freeman is committed to advancing impactful cancer therapies and fostering high-performing, cross-functional teams. Freeman earned a Bachelor of Science in Pharmacology from Leeds University and a PhD in Neurophysiology from Manchester University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices